Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nada Dimkovic

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Nephron|July 18, 2015
Randomized, Double-Blind, Placebo-Controlled, Withdrawal Study of Colestilan after Dose Titration in Chronic Kidney Disease Dialysis Patients with HyperphosphatemiaJoachim Hertel, Francesco Locatelli, Goce Spasovski, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 5, 2013
The effects of colestilan versus placebo and sevelamer in patients with CKD 5D and hyperphosphataemia: a 1-year prospective randomized studyFrancesco Locatelli, Goce Spasovski, Nada Dimkovic, et al.
Plos One|September 13, 2018
Prevalence and factors associated with self-reported kidney disease among Serbian adults: Results of 2013 National Health SurveyDragana Jovic, Nada Dimkovic, Ivana Rakocevic, et al.
General Physiology and Biophysics|November 7, 2009
Screening of vascular calcifications in patients with end-stage renal diseasesTatjana Damjanovic, Zivka Djuric, Natasa Markovic, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|November 6, 2009
Assisted peritoneal dialysis: what is it and who does it involve?Nada Dimkovic, Vikram Aggarwal, Saimah Khan, et al.
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|July 28, 2017
Association between age and cardiovascular status by echosonography in asymptomatic predialysis patients with chronic kidney diseaseBiserka Tirmenstajn-Jankovic, Nada Dimkovic, Zoran Radojicic, et al.
Dose-Response : a Publication of International Hormesis Society|September 19, 2022
Biomarkers and Predictors of Adverse Cardiovascular Events in Different Stages of Chronic Kidney DiseaseBojan Stopic, Branislava Medic-Brkic, Katarina Savic-Vujovic, et al.
The Tohoku Journal of Experimental Medicine|August 8, 2017
The 5A Allele of the MMP3-Gene Promoter Polymorphism Is a Risk Factor for Poor Outcome of Hemodialysis PatientsJelena Tosic Dragovic, Jovan Popovic, Petar Djuric, et al.
Toxins|September 26, 2021
Biomarkers of Uremic CardiotoxicityBojan Stopic, Sandra Dragicevic, Branislava Medic-Brkic, et al.
Fertility and Sterility|June 15, 2004
Effect of tibolone on markers of cardiovascular disease risk in postmenopausal women undergoing hemodialysis: a pilot studyJulia E Ostberg, Tatjana Damjanovic, Nada Dimkovic, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Nephron|July 18, 2015
Randomized, Double-Blind, Placebo-Controlled, Withdrawal Study of Colestilan after Dose Titration in Chronic Kidney Disease Dialysis Patients with HyperphosphatemiaJoachim Hertel, Francesco Locatelli, Goce Spasovski, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 5, 2013
The effects of colestilan versus placebo and sevelamer in patients with CKD 5D and hyperphosphataemia: a 1-year prospective randomized studyFrancesco Locatelli, Goce Spasovski, Nada Dimkovic, et al.
Plos One|September 13, 2018
Prevalence and factors associated with self-reported kidney disease among Serbian adults: Results of 2013 National Health SurveyDragana Jovic, Nada Dimkovic, Ivana Rakocevic, et al.
General Physiology and Biophysics|November 7, 2009
Screening of vascular calcifications in patients with end-stage renal diseasesTatjana Damjanovic, Zivka Djuric, Natasa Markovic, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|November 6, 2009
Assisted peritoneal dialysis: what is it and who does it involve?Nada Dimkovic, Vikram Aggarwal, Saimah Khan, et al.
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|July 28, 2017
Association between age and cardiovascular status by echosonography in asymptomatic predialysis patients with chronic kidney diseaseBiserka Tirmenstajn-Jankovic, Nada Dimkovic, Zoran Radojicic, et al.
Dose-Response : a Publication of International Hormesis Society|September 19, 2022
Biomarkers and Predictors of Adverse Cardiovascular Events in Different Stages of Chronic Kidney DiseaseBojan Stopic, Branislava Medic-Brkic, Katarina Savic-Vujovic, et al.
The Tohoku Journal of Experimental Medicine|August 8, 2017
The 5A Allele of the MMP3-Gene Promoter Polymorphism Is a Risk Factor for Poor Outcome of Hemodialysis PatientsJelena Tosic Dragovic, Jovan Popovic, Petar Djuric, et al.
Toxins|September 26, 2021
Biomarkers of Uremic CardiotoxicityBojan Stopic, Sandra Dragicevic, Branislava Medic-Brkic, et al.
Fertility and Sterility|June 15, 2004
Effect of tibolone on markers of cardiovascular disease risk in postmenopausal women undergoing hemodialysis: a pilot studyJulia E Ostberg, Tatjana Damjanovic, Nada Dimkovic, et al.
Pageof 5